NATURALLY-OCCURRING ISOQUINOLINES PERTURB MONOAMINE METABOLISM IN THEBRAIN - STUDIED BY IN-VIVO MICRODIALYSIS
Citation
W. Maruyama et al., NATURALLY-OCCURRING ISOQUINOLINES PERTURB MONOAMINE METABOLISM IN THEBRAIN - STUDIED BY IN-VIVO MICRODIALYSIS, Journal of neural transmission, 94(2), 1993, pp. 91-102
Categorie Soggetti
Neurosciences
SICI code
0300-9564(1993)94:2<91:NIPMMI>2.0.ZU;2-A
Abstract
Naturally occurring isoquinolines affected the monoamine metabolism in
the rat striatum, as proved by in vivo microdialysis technique. By an
alysis of monoamines and their metabolites in the dialysate, dopamine-
derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines were found to in
hibit monoamine oxidase and catechol-O-methyltransferase activity. 1-M
ethyl- and ethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline were fou
nd to inhibit activity of type A monoamine oxidase most markedly. To c
ompare the structure-activity relationship, corresponding isoquinoline
s without a catechol structure were also examined. The inhibition by c
atechol isoquinolines was more manifest than those without a catechol
structure. Among latter isoquinolines, N-methyl-isoquinolinium ion was
the most potent inhibitor of monoamine oxidase. In addition, catechol
isoquinolines increased monoamine levels in the brain. The number and
the site of the methyl group are essentially required for the inhibit
ion of monoamine oxidase and a catechol structure for that of catechol
-O-methyl-transferase. These results are discussed in relation to poss
ible involvement of these isoquinolines to the clinical features of so
me neuro-psychiatric diseases, such as alcoholism or in L-DOPA therapy
.